Pages that link to "Q43747182"
Jump to navigation
Jump to search
The following pages link to Aluminum compounds used as adjuvants in vaccines (Q43747182):
Displaying 50 items.
- Advances in aluminum hydroxide-based adjuvant research and its mechanism (Q27007659) (← links)
- Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts (Q28387541) (← links)
- Detoxification of endotoxin by aluminum hydroxide adjuvant (Q31887812) (← links)
- Distribution of adsorbed antigen in mono-valent and combination vaccines (Q33202538) (← links)
- Technologies for the design, discovery, formulation and administration of vaccines (Q34189242) (← links)
- Towards the rational design of Th1 adjuvants (Q34324978) (← links)
- Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice (Q34430681) (← links)
- Mechanisms of stimulation of the immune response by aluminum adjuvants (Q34787679) (← links)
- Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactions (Q34976001) (← links)
- Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line (Q35239021) (← links)
- Aluminum inclusion macrophagic myofasciitis: a recently identified condition. (Q35643935) (← links)
- Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition (Q35665569) (← links)
- Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen (Q35682493) (← links)
- Aluminium adjuvants--in retrospect and prospect (Q35865322) (← links)
- Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment (Q35887653) (← links)
- Aluminium compounds for use in vaccines (Q35915759) (← links)
- Cross-linked protein crystals for vaccine delivery (Q36420836) (← links)
- Disparate adjuvant properties among three formulations of "alum" (Q36522053) (← links)
- Developing an HPV vaccine to prevent cervical cancer and genital warts (Q36731663) (← links)
- Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation (Q36968256) (← links)
- Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine (Q36994089) (← links)
- Superovulation with a single administration of FSH in aluminum hydroxide gel: a novel superovulation method for cattle (Q37369699) (← links)
- A Rational, Systematic Approach for the Development of Vaccine Formulations (Q37846559) (← links)
- Physicochemical and functional characterization of vaccine antigens and adjuvants (Q38202170) (← links)
- The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm. (Q38453147) (← links)
- Novel adjuvant strategies for experimental malaria and AIDS vaccines (Q40844499) (← links)
- From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light Scattering (Q40959511) (← links)
- New developments in adjuvants (Q41412446) (← links)
- Mechanism of immunopotentiation and safety of aluminum adjuvants. (Q42036323) (← links)
- Adjuvant potential of aggregate-forming polyglutamine domains (Q43971720) (← links)
- Elimination of aluminum adjuvants (Q44106837) (← links)
- Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen (Q44788256) (← links)
- Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy (Q44908820) (← links)
- Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid (Q45238444) (← links)
- Enhancement of the immune response to hepatitis B virus vaccine by antigen specific IgM. (Q45740854) (← links)
- Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. (Q45974698) (← links)
- Concentration determination of a recombinant vaccine antigen adsorbed onto an alum adjuvant by chemiluminescent nitrogen detection (Q46382809) (← links)
- In vivo absorption of aluminium-containing vaccine adjuvants using 26Al (Q48642749) (← links)
- Haemophilus somnus-induced IgE in calves vaccinated with commercial monovalent H. somnus bacterins (Q50119334) (← links)
- Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro (Q50778699) (← links)
- Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. (Q52000133) (← links)
- The importance of surface charge in the optimization of antigen-adjuvant interactions (Q56460204) (← links)
- Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action (Q59137099) (← links)
- Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. (Q64881146) (← links)
- Characterization of antacid compounds containing both aluminum and magnesium. I. Crystalline powders (Q72935936) (← links)
- Stability of aluminium-containing adjuvants during aging at room temperature (Q73549075) (← links)
- The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens (Q73865779) (← links)
- Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure (Q74128260) (← links)
- Vaccines and their transfection potency (Q77879184) (← links)
- Stability of aluminium-containing adjuvants to autoclaving (Q78036053) (← links)